$MYSE

Myseum.AI, Inc.

CIK:0001648960|SEC Filings

Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Income Statement [Abstract]
NET REVENUES	$ 37	$ 78	$ 110	$ 161
OPERATING EXPENSES:
Compensation and related expenses	1,187,674	660,534	1,984,215	1,576,696
Marketing and advertising expenses	131,451	59,121	363,190	92,958
Professional and consulting expenses	671,720	274,225	1,188,902	604,823
General and administrative expenses	161,503	200,359	301,584	353,806
Total operating expenses	2,152,348	1,194,239	3,837,891	2,628,283
LOSS FROM OPERATIONS	(2,152,311)	(1,194,161)	(3,837,781)	(2,628,122)
OTHER INCOME (EXPENSES):
Interest income, net	11,947	49,639	29,807	90,975
Unrealized loss on equity securities	(910,000)		(2,104,000)
Total other income (expenses), net	(898,053)	49,639	(2,074,193)	90,975
LOSS FROM CONTINUING OPERATIONS	(3,050,364)	(1,144,522)	(5,911,974)	(2,537,147)
DISCONTINUED OPERATIONS:
Loss from discontinued operations, net of tax		(212,667)		(439,152)
Total loss from discontinued operations, net		(212,667)		(439,152)
NET LOSS	(3,050,364)	(1,357,189)	(5,911,974)	(2,976,299)
Net loss of former subsidiary attributable to noncontrolling interest of discontinued operations		140,317		286,231
NET LOSS ATTRIBUTABLE TO MYSEUM.AI, INC. SHAREHOLDERS	$ (3,050,364)	$ (1,216,872)	$ (5,911,974)	$ (2,690,068)
NET LOSS PER COMMON SHARE:
Basic - continuing operations (in Dollars per share)	$ (0.61)	$ (0.27)	$ (1.28)	$ (0.61)
Diluted - continuing operations (in Dollars per share)	(0.61)	(0.27)	(1.28)	(0.61)
Basic - discontinued operations (in Dollars per share)		(0.02)		(0.04)
Diluted - discontinued operations (in Dollars per share)		(0.02)		(0.04)
Basic net loss per common share attributable to Myseum.AI, Inc. shareholders (in Dollars per share)	(0.61)	(0.29)	(1.28)	(0.65)
Diluted net loss per common share attributable to Myseum.AI, Inc. shareholders (in Dollars per share)	$ (0.61)	$ (0.29)	$ (1.28)	$ (0.65)
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING:
Basic (in Shares)	4,980,683	4,209,329	4,633,104	4,149,660
Diluted (in Shares)	4,980,683	4,209,329	4,633,104	4,149,660

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Statement of Cash Flows [Abstract]
Net loss	$ (5,911,974)	$ (2,976,299)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	8,528	11,209
Amortization of right-of-use asset	24,879	10,318
Stock-based compensation	454,231	312,174
Stock-based professional fees	532,516	1,492
Changes in accrued interest income	52,043
Unrealized loss on equity securities	2,104,000
Changes in operating assets and liabilities:
Accounts receivable	31	(13)
Prepaid expenses	149,158	55,128
Assets of discontinued operations		139,898
Accounts payable and accrued expenses	(151,813)	(132,181)
Contract liabilities	(10)	17
Operating lease liability	(24,246)	(3,562)
Liabilities of discontinued operations		99,609
NET CASH USED IN OPERATING ACTIVITIES	(2,762,657)	(2,482,210)
CASH FLOWS FROM INVESTING ACTIVITIES:
Proceeds from sale of short-term investments	4,017,475	2,963,546
Purchase of short-term investments	(3,143,805)	(5,317,735)
Purchases of property and equipment		(4,475)
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES	873,670	(2,358,664)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from sale of common stock, net	3,208,239	4,532,000
Payment of deferred offering costs	(194,133)	(54,028)
NET CASH PROVIDED BY FINANCING ACTIVITIES	3,014,106	4,477,972
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	1,125,119	(362,902)
CASH AND CASH EQUIVALENTS - beginning of period	749,030	766,985
CASH AND CASH EQUIVALENTS - end of period	1,874,149	404,083
Cash paid for:
Interest	3,454	4,250
Income taxes
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Warrants issued for future services	279,975
Common stock issue for future services	59,800
Common stock issued for future sale pursuant to ATM offering	80	75
Amortization of deferred offering costs to Equity	144,572
Initial recording and changes in noncontrolling interest deficit		181,530
Initial recognition of right-of-use asset and lease liability		$ 244,793

Consolidated Balance Sheets - USD ($)	Jun. 30, 2026	Dec. 31, 2025
CURRENT ASSETS:
Cash and cash equivalents	$ 1,874,149	$ 749,030
Short-term investments, at fair value	2,056,196	2,981,909
Accounts receivable	52	83
Prepaid expenses	220,543	239,167
Total Current Assets	4,150,940	3,970,189
NON-CURRENT ASSETS:
Deferred offering costs	128,206	78,645
Property and equipment, net	8,843	17,371
Investment in equity securities, at fair value	816,000	2,920,000
Operating lease right-of-use asset, net	186,324	211,203
Total Non-current Assets	1,139,373	3,227,219
Total Assets	5,290,313	7,197,408
CURRENT LIABILITIES:
Accounts payable and accrued expenses	721,878	873,691
Operating lease liability, current portion	55,917	51,040
Contract liabilities	49	59
Total Current Liabilities	777,844	924,790
LONG-TERM LIABILITIES:
Operating lease liability, less current portion	138,812	167,935
Total Long-Term Liabilities	138,812	167,935
Total Liabilities	916,656	1,092,725
Commitments and Contingencies (Note 11)
STOCKHOLDERS’ EQUITY:
Common stock ($0.0001 par value; 180,000,000 shares authorized; 5,263,375 and 4,331,274 shares issued and 5,196,430 and 4,264,329 shares outstanding on June 30, 2026 and December 31, 2025, respectively)	526	433
Common stock to be issued (139 shares on June 30, 2026 and December 31, 2025)
Additional paid-in capital	65,663,594	61,482,739
Treasury stock, at cost (66,945 shares and 66,945 on June 30, 2026 and December 31, 2025, respectively)	(397,969)	(397,969)
Accumulated deficit	(60,892,494)	(54,980,520)
Total Stockholders’ Equity	4,373,657	6,104,683
Total Liabilities and Stockholders’ Equity	5,290,313	7,197,408
Series A Preferred Stock
STOCKHOLDERS’ EQUITY:
Preferred stock, value
Series B Preferred Stock
STOCKHOLDERS’ EQUITY:
Preferred stock, value